BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11010792)

  • 41. Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital.
    Chan RC; Chan JY; Wei WI
    Laryngoscope; 2012 Dec; 122(12):2749-53. PubMed ID: 23161468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality assurance in interventional cardiology. British Cardiovascular Intervention Society.
    Perrins J
    Heart; 1999 Oct; 82 Suppl 2(Suppl 2):II23-6. PubMed ID: 10490585
    [No Abstract]   [Full Text] [Related]  

  • 43. Rapid access for patients with head and neck lumps.
    Robinson J; Chew F
    Nurs Stand; 2001 Sep 26-Oct 2; 16(2):33-7. PubMed ID: 11977663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
    Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoscopic management of upper esophageal strictures after treatment of head and neck malignancy.
    Ahlawat SK; Al-Kawas FH
    Gastrointest Endosc; 2008 Jul; 68(1):19-24. PubMed ID: 18355822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Multidisciplinary treatment of head and neck cancer].
    Inuyama Y; Kohno N; Fujii M; Tanaka J; Takaoka T; Hosoda H; Kawaura M; Toji M; Tanaka K; Kawatani A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):993-9. PubMed ID: 2730039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
    Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
    Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recent treatment modality for advanced head and neck carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1657-64. PubMed ID: 9757189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical quality control in head and neck cancer. Study 73-03 of the Radiation Therapy Oncology Group.
    Jacobs JR; Pajak TF; Snow JB; Lowry LD; Kramer S
    Arch Otolaryngol Head Neck Surg; 1989 Apr; 115(4):489-93. PubMed ID: 2647106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic factors and adjuvant treatment effects on survival in adult head and neck synovial cell sarcoma.
    Crowson MG; Lalich I; Keeney MG; Garcia JJ; Price DL
    Head Neck; 2015 Mar; 37(3):375-80. PubMed ID: 24430934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence.
    Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Bhamidipati PV; Karlsson U; Nguyen PD; Alfieri A; Nguyen LM; Lemanski C; Chan W; Rose S; Sallah S
    Radiother Oncol; 2006 Sep; 80(3):302-6. PubMed ID: 16890314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics and medical-care-seeking of head and neck cancer patients: a population-based cross-sectional survey.
    Väisänen JA; Syrjälä AM; Pesonen PR; Pukkila MJ; Koivunen PT; Alho OP
    Oral Oncol; 2014 Aug; 50(8):740-5. PubMed ID: 24856187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Publication of the British Association of Head and neck Oncologists (BAHNO) Standards 2020.
    Brennan PA
    J Oral Pathol Med; 2021 Mar; 50(3):261. PubMed ID: 33733532
    [No Abstract]   [Full Text] [Related]  

  • 55. Quality assurance in head and neck cancer surgery: where are we, and where are we going?
    Simon C; Dietz A; Leemans CR
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):151-156. PubMed ID: 30664051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An audit of clinical resources available for the care of head and neck cancer patients in England.
    Bradley PJ; Zutshi B; Nutting CM
    Clin Oncol (R Coll Radiol); 2005 Dec; 17(8):604-9. PubMed ID: 16372485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Head and neck cancer surgery provision in England: A current analysis of contributing specialties caseloads.
    Islam S; Wates E; Hayter JP
    Br J Oral Maxillofac Surg; 2017 Feb; 55(2):189-191. PubMed ID: 27378740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of process standards on survival of patients with head and neck cancer in the south and west of England.
    Birchall M; Bailey D; King P;
    Br J Cancer; 2004 Oct; 91(8):1477-81. PubMed ID: 15467772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From quantity to quality: the central cardiac audit database project.
    Rickards A; Cunningham D
    Heart; 1999 Oct; 82 Suppl 2(Suppl 2):II18-22. PubMed ID: 10490584
    [No Abstract]   [Full Text] [Related]  

  • 60. Two-week rule for suspected head and neck cancer. A study of compliance and effectiveness.
    Duvvi SK; Thomas L; Vijayanand S; Reddy KT
    J Eval Clin Pract; 2006 Dec; 12(6):591-4. PubMed ID: 17100857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.